SPACA6 and breast cancer: Initially, using specific small interfering RNA (siRNA) technology, we effectively reduced the expression of SPACA6P-AS in the BC cell lines MDA-MB-231 and MCF-7, as evidenced by quantitative real-time PCR results (Fig. 11A).